VASCULAR PHARMACEUTICALS

Basic Information

1088 KNOLLRIDGE RD
BURLINGTON, NC, 27217-

Company Profile

n/a

Additional Details

Field Value
DUNS: 601953974
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Development of a novel method for inhibiting diabetic retinopathy

    Amount: $172,913.00

    DESCRIPTION (provided by applicant): The long-term objective of the proposed study is to develop a monoclonal antibody that inhibits the progression of diabetic retinopathy. Insulin-like growth factor ...

    STTR Phase I 2012 Department of Health and Human Services
  2. Development of a Novel Method for Inhibiting Atherosclerosis in Diabetes

    Amount: $1,218,280.00

    DESCRIPTION (provided by applicant): The long term objective of the proposed studies is to develop a monoclonal antibody that can be administered safely to patients with diabetes that will inhibit ath ...

    STTR Phase II 2009 Department of Health and Human Services
  3. Development of a Novel Method for Inhibiting Atherosclerosis in Diabetes

    Amount: $210,260.00

    DESCRIPTION (provided by applicant): The long term objective of the proposed studies is to develop a monoclonal antibody that can be administered safely to patients with diabetes to determine if it ca ...

    STTR Phase I 2006 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government